Literature DB >> 6817063

Subacute sclerosing panencephalitis surveillance - United States.

.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 6817063

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  7 in total

1.  Vaccine safety: An evolving evidence-based science.

Authors:  Bruce M McClenathan; Kathryn M Edwards
Journal:  Br J Clin Pharmacol       Date:  2019-08-19       Impact factor: 4.335

2.  Seizure Risk with Vaccination.

Authors:  Anne T. Berg
Journal:  Epilepsy Curr       Date:  2002-01       Impact factor: 7.872

3.  A role for dual viral hits in causation of subacute sclerosing panencephalitis.

Authors:  Michael B A Oldstone; Samuel Dales; Antoinette Tishon; Hanna Lewicki; Lee Martin
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

Review 4.  Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.

Authors:  Craig Campbell; Simon Levin; Peter Humphreys; Wikke Walop; Renee Brannan
Journal:  BMC Pediatr       Date:  2005-12-15       Impact factor: 2.125

5.  Subacute sclerosing panencephalitis: A clinical appraisal.

Authors:  Sujit Abajirao Jagtap; M D Nair; Harsha J Kambale
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

6.  Subacute Sclerosing Panencephalitis in a Child Suffering from Human Immunodeficiency Virus on "Highly Active Antiretroviral Therapy" - Can This be Another Instance of Immune Reconstitution Inflammatory Syndrome?

Authors:  Ashutosh Gupta; Suman Kushwaha; Mushbiq Manzoor; Shah Faisal Ahmad Tarfarosh
Journal:  Cureus       Date:  2017-06-13

Review 7.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.